Skip to main content

Table 2 Demographic aspects and medical history of the included patients

From: Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study)

  Month 0 Month 6
Number of patients 1490 1354
Age (years) 36.7 ± 0.3 36.8 ± 10.9
Sex (% males) 65.2 % 64.6 %
Marital status (% patients)
 Married or cohabiting 17.2 % 16.9 %
 Single 68.9 % 68.8 %
 Divorced, widowed, separated 13.9 % 14.3 %
Patients with children (% patients) 27.6 % 27.8 %
Accommodation (% patients)   
 Independent housing 62.6 63.1
 Dependent housing 20.9 20.7
 Homeless housing 1.3 % 1.3 %
 Hotel 0.9 % 1.0 %
 Institutional center/Foundation 8.9 % 8.7 %
 Retiring home 0.5 % 0.6 %
 Other 4.8 % 4.7 %
Current employment status (% patients)
 Employee 12.2 % 11.7 %
 Student or in training 6.3 % 5.9 %
 Help Center for Labor 7.2 % 7.3 %
 Unemployed or retired 9.6 % 9.5 %
 Freelancer 1.0 % 1.1 %
 Disabled or sick leave for psychiatric disorder 56.4 % 57.0 %
 Status unknown 0.8 % 0.9 %
 Other 6.5 % 6.5 %
Psychiatric history
DSM-IV diagnostic (% patients)
 Schizophrenia 76.4 % 76.4 %
 Schizophreniform disorder 23.6 % 23.6 %
Chronicity (% patients)
 ≤ 5 years 30.7 % 30.3 %
 > 5 and ≤ 10 years 31.8 % 31.9 %
 > 10 and ≤ 15 years 16.6 % 16.6 %
 >15 years 20.8 % 21.2 %
  1. Values are given as mean ± SEM or as % of patients. M0, month 0 (inclusion). M6, month 6 (end of study)